year in review - uts.edu.au · contracted chere to carry out evaluations of their appraisals....

YEAR IN REVIEW 2017-2018

CONTENTS

DIRECTOR’S REPORT 1

NEW PROJECTS IN 2017/2018 2

NEW PEER REVIEWED GRANTS in 2017/2018 6

ACHIEVEMENTS 9

JOURNAL EDITORSHIPS 9

COMMITTEE MEMBERSHIPS 9

VISITORS TO CHERE 10

VISITING SPEAKERS 10

NEW STAFF 10

CURRENT PHD STUDENTS 11

PEER-REVIEWED PUBLICATIONS 2018 12

BOOK CHAPTERS 2018 14

REPORTS 2018 14

CONFERENCE PRESENTATIONS 2018 14

PEER-REVIEWED PUBLICATIONS 2017 15

BOOK CHAPTERS 2017 16

CONFERENCE PRESENATIONS 2017 16

YEAR IN REVIEW | 2017-2018 page 1

DIRECTOR’S REPORT

Rosalie Viney

It is with great pride and pleasure that we present

the 2017-18 Annual Report for the Centre for Health

Economics Research and Evaluation (CHERE).

CHERE has a strong history in research that has

impact on the health system, both through our

contract research and through our investigator

initiated research.

This report includes many examples of these

research projects and reflects emerging themes

within the Centre, including in the health economics

of ageing and the health economics of end-of-life

care.

The Centre’s staff have continued to excel in

undertaking outstanding research, which reflect their

commitment to making a difference in the health

system. I invite you to read about our projects and

other achievements within this Annual Report.

The research reported here builds on the 25+ year

history of CHERE in contributing to health

economics research and policy development in

Australia. It also reflects the international profile of

CHERE, with increasing numbers of international

research projects and collaborations.

The wonderful collaborative research culture at

CHERE places a strong emphasis on mentoring of

early and mid-career researchers and on capacity

building. Our staff contribute enormously to this

through their engagement in activities such as our

weekly workshops, and research seminars as well

as active participation in research themes expert

and our PhD groups. I thank all our staff for their

incredible hard work on projects, on their own

research projects including PhD projects.

I would also like to thank the senior staff at CHERE

for their support, advice and encouragement

throughout the year. I am supported by a wonderful

management team including the two Deputy

Directors, Stephen Goodall and Kees Van Gool and

our Director of Strategy, Jane Hall. We have

continued to have outstanding additional leadership

from Marion Haas and Mike Woods, and we have

welcomed Debbie Street to the senior team –

Debbie brings a wealth of experience in

mathematics and statistics as well as a long history

of collaboration with CHERE, and it is wonderful to

have her as part of the team. I would also like to

thank our wonderful support staff who work

tirelessly to keep the Centre running. We have a

huge debt of gratitude to Gretchen Togle who

retired in 2017 after many years of incredible and

loyal service to the Centre. It has been a pleasure

to welcome Lili Sanacore as the new Executive

Assistant to the Management team – Lili has been a

wonderful addition to our team. Vanessa Nolasco

and Liz Chinchen have also continued to provide

wonderful support. We also thank the staff of the

Business School and the Research and Innovation

Office who provide important support to the Centre

in achieving our goals.

Finally I would like to acknowledge the wonderful support from our Advisory Board for their guidance, advice and support throughout the past year.

I invite you to read our Annual Report and celebrate the achievements of CHERE staff during the 2017-2018 year.

Rosalie Viney

Contact us:

www.chere.uts.edu.au

Director: Prof Rosalie Viney

Address:

CHERE UTS PO Box 123 Broadway. NSW 2007 t: +61 2 9514 4720 e: [email protected]

http://www.chere.uts.edu.au/

mailto:[email protected]


NEW PROJECTS IN

2017/2018

Victorian Healthy Homes Program

The Victorian Healthy Homes Program is a Victorian Government home energy efficiency program that provides free home energy upgrades to up to 1000 vulnerable Victorians who live with complex healthcare needs, and have low incomes, in Melbourne's western suburbs and the Goulburn Valley. The program aims to improve indoor winter temperatures and reduce energy bills of vulnerable Victorians. The Program has been specifically designed to measure the health, energy, and climate change co-benefits of public investment in improving home energy efficiency and warmth. This is a joint project with the UTS Institute for Sustainable Futures (ISF).

Funding Source: Sustainability Victoria Investigators: Rosalie Viney, Kees van Gool, Tom Longden, Patsy Kenny, Jane Hall, Stephen Goodall, Phil Haywood, Paula Cronin, Steve Mohr1, Kerryn Wilmot1, Jay Falletta1, Benjamin Madden1, Brendan Mulhern, Scott Kelly

1. Institute for Sustainable Futures (ISF), UTS

Demonstrating the Role of Intermediate Clinical Endpoints for Cancer of the Prostate (ICECaP) in Estimating Economic Value

This project investigates whether decisions about introducing new treatments can be made reliably on the basis of how those treatments impact on cancer progression as a means of predicting longer term survival and quality of life for prostate cancer patients.

Funding source: ANZUP Cancer Trials Group Ltd Investigators: Christopher Sweeney1, Ian Davis1, Richard De Abreu Lourenço, Marion Haas

1. ANZUP Scientific Advisory Committee

Health Technology Assessments and critiques for MSAC

The role of MSAC is to provide recommendations to the Australian Minister for Health regarding the evidence relating to the safety, effectiveness and cost-effectiveness of health technologies and medical procedures.

The recommendations of MSAC are used by the Australian federal government to decide whether public funding via MBS should be granted.

CHERE is undertaking health technology assessments for the Royal Australasian College of Surgeons.

Funding source: Royal Australasian College of Surgeons Investigators: Stephen Goodall

Independent Review Work with Agency for Care Effectiveness (ACE), Singapore

The Agency for Care Effectiveness (ACE) was established by the Singapore Ministry of Health (MOH) in 2015 as the national Health Technology Assessment (HTA) agency. The Agency conducts appraisals which inform decision-making on coverage issues and which help define appropriate care in the Singapore context. The appraisals are currently in the areas of drugs, devices, diagnostics and procedures. ACE has contracted CHERE to carry out evaluations of their appraisals.

Funding source: Ministry of Health, Singapore Investigators: Stephen Goodall, Richard De Abreu Lourenço, Jane Hall, Rosalie Viney, Marion Haas, Phil Haywood, Paula Cronin, Sheena Arora, Jody Church, Sopany Saing, Elena Meshcheriakova, Kathleen Manipis, Naomi van Der Linden, Debbie Street, Patsy Kenny

The implementation of a Decision Aid for women with early-stage breast cancer considering contralateral prophylactic mastectomy: a pilot study

The aim of this project is to use an implementation theoretical approach to gain understanding of the barriers and facilitators to contralateral prophylactic mastectomy (CPM) decision aid (DA) adoption, to inform development of tailored strategies to optimize the likelihood of successful implementation of the DA and improve treatment decision making for women with breast cancer.

Funding source: ANZ Breast Cancer Trials Group Limited Investigators: Phyllis Butow1, Jesse Jansen1, David Porter2, Nicole Rankin3, Richard De Abreu Lourenço, Jenny Anderson4, Nick Zdenkowski5, Christobel Saunders6


1. University of Sydney

2. University of Wollongong

3. Cancer Council NSW

4. University of Melbourne

5. Hunter Cancer Centre

6. University of Western Australia

Advise on the design, analysis and evaluation of a preference-based measure to value quality of life for people with a diagnosis of dementia or cognitive decline

The aim of this project is to develop a preference based measure to value quality of life for people with a diagnosis of dementia or cognitive decline, using the inter-disciplinary expertise of consumers, policy makers and researchers.

Funding source: University of Queensland Investigators: Brendan Mulhern

Assisting in developing a trial in early stage non-small cell lung cancer (NSCLC) which will compare surgery with a form of radiation therapy called stereotactic ablative radiotherapy (SABR)

The aim of this research is to undertake preliminary research to assist in developing a trial in early stage non-small cell lung cancer (NSCLC) which will compare surgery with a form of radiation therapy called stereotactic ablative radiotherapy (SABR).

Funding source: Trans-Tasman Radiation Oncology Group Ltd Investigators: Fiona Hegi-Johnson1, Marion Haas, Richard De Abreu Lourenço, Rosalie Viney 1. University of Newcastle

Crusted Scabies Elimination Program

Working with local health services (including Aboriginal Community Controlled Health Organisations), One Disease has created a Crusted Scabies Elimination Plan this program aims to eliminate Crusted Scabies from Australia by the end of 2022. The goal towards elimination is twofold: to improve detection, diagnosis and treatment of Crusted Scabies and to prevent recurrences of Crusted Scabies in people who have been successfully treated. CHERE will conduct an evaluation of the Crusted Scabies Elimination program in the Northern Territory.

Funding source: One Disease Investigators: Karen Gardner1, Jason Agostino1, Carolyn Renehan1, Helen

Dickinson1, Kees van Gool, Rosalie Viney, Naomi van der Linden

1. UNSW

Evaluation of the Statewide Eyesight Preschooler Screening (StEPS) Program

This project will evaluate the The StEPS program which is a universal free statewide vision screening program targeting four year old children via preschools, childcare and other children’s services. StEPS has been operating since 2008 where it formalises the recommendation for vision screening as part of regular health checks, as documented in the NSW Personal Health Record.

Funding source: NSW Health Administration Corporation Investigators: Roberta Ryan1, Andy Goodall1, Thomas Lopata2, Amanda French2, Paula Cronin, Stephen Goodall, Kathyrn Rose2, Rosalie Viney

1.Institute for Public Policy and Governance (IPPG), UTS 2. Graduate School of Health, UTS

Evaluation of the Western NSW Integrated Care Strategy

The WNSW Integrated Care (IC) Strategy is a ground-breaking approach to implementing locally driven, regionally enabled integrated care across a large rural health district. The strategy provides the opportunity for real reform in health care and also to build the evidence base for system-wide approaches to integrated care. The evaluation consists of a mixed methods theory driven approach, combining qualitative, quantitative and economic elements.

Funding source: Western Sydney Local Health District Investigators: Mark Harris1, David Lyle2, Jane Hall, Karen Edwards3, Karen Gardner1, Sue Kirby4, Megan Passey5, Kees van Gool, Serena Yu

1.UNSW 2. University of Sydney 3. Counterpoint Consulting Pty Ltd 4. Broken Hill University 5. Australian Rural Health Research Collaboration

Learning and Growth for Mental Health – Evaluation of the South Eastern Sydney Recovery College

The Recovery College Model has recently emerged as an inventive approach for providing mental health education to people


who have psychiatric experiences, their families and mental health service providers. The aims of this study are to: determine the effectiveness of the Recovery College Model for the Australian context, examine the benefits of a ‘co-production’ approach, and identify features of best practice in recovery oriented mental health service provision that can lead to improved outcomes for consumers and economic benefits for the government and community.

Funding source: NSW Health South Eastern Sydney Local Health District Cultural Diversity Enhancement Grant Program Investigators: Joanne Sommer1, Jane Stein-Parbury2. Katherine Gill3, Vicki Katsifis4, Paula Cronin

1. South Eastern Sydney Local Health District 2. Graduate School of Health, UTS 3. Consumer Led Research Network 4. South Eastern Sydney Recovery College

Pharma cluster Australian expert

The Australian Taxation Office (ATO) has contracted CHERE to provide expertise for the ATO’s Pharmaceutical Cluster.

Funding Source: Australian Taxation Office Investigators: Rosalie Viney

Post-reform accommodation payments in

residential aged care facilities

The aims of this project are to analyse trends

in Refundable Accommodation Deposits

(RADs) across aged care providers following

the commencement of accommodation reform

from 1 July 2014; conduct analysis and identify

potential underlying factors that may explain

any existing trends; project the possible effects

of transition and medium-term changes in the

potential demand in residential care. An

economic evaluation of residential care

payment patterns will also be conducted.

Funding source: Aged Care Guild Ltd

Investigators: Mike Woods, Olukorede

Abiona, Kees van Gool

Precision medicine and health economics

The introduction of new genetic technologies can have significant costs and benefits from different perspectives in the health system. CHERE was contracted to contribute to a book chapter on the health economics of precision medicine.

Funding source: Australian Council of Learned Academies (ACOLA) Investigators: Rosalie Viney, Jane Hall, Kees van Gool, Phil Haywood, Richard De Abreu Lourenço

Provision of Product Evaluation Services

The aim of this project is to provide evaluation services of pharmaceuticals for the TGA. This comprises review and critical evaluation of quality, safety and efficacy data as submitted by pharmaceutical companies.

Funding source: Therapeutic Goods Administration (TGA) Investigators: Phil Haywood, Kathleen Manipis, Richard De Abreu Lourenço, Naomi van der Linden, Stephen Goodall, Patsy Kenny, Rosalie Viney

Quantitative evaluation of patient preferences for diabetes interventions

The aim of this project is to investigate the relative importance of a variety of attributes of diabetes treatments. The outcomes from the study have potential to be used to provide inputs into future PBAC submissions, such as willingness to pay and utility values.

Funding source: Novo Nordisk Pharamaceuticals Pty Ltd Investigators: Stephen Goodall, Alison Pearce, Rosalie Viney, Debbie Street

The identification of unmet need for people requiring Palliative Care

The aim of this project is to undertake a mapping of data sources relating to the availability of, and unmet need for, palliative care for adults experiencing an expected death in a particular region and to demonstrate the conclusions that could be drawn from the data in terms of the factors contributing to limitations in accessibility of palliative care in that region. The methodology will then be refined to be applied to the analysis in a second region under a further phase of the project.

Funding source: Palliative Care Australia Investigators: Mike Woods, Deborah Parker1, Meera Agar1, Kees van Gool, Olukerede Abiona

1. Graduate School of Health UTS


Understanding how patients and carers make decisions in Spinal Muscular Atrophy Treatment

The aim of this project is to design and implement a discrete choice experiment (DCE) to determine the acceptability (preferences and values) of different intervention strategies for people with Spinal Muscular Atrophy (SMA) in a health care setting. Funding source: Sydney Children’s Hospital Foundation Grant Investigators: Michelle Farrar1, Nadine Kasparian2, Richard De Abreu Lourenço, Kate Carey1, Hugo Sampaio1, Debbie Street 1. Sydney Children’s Hospital 2. UNSW

Extending the QALY project – testing the face and content validity of candidate items within the Australian context This is a collaborative project between the EuroQol group, Sheffield University, NICE, University of Kent and the Office of Health Economics. The aim of the project is to develop a broad measure of quality of life for use in economic evaluations across health and social care. Funding source: EuroQol Investigators: Brendan Mulhern, Lidia Engel1, Lisa Hanna1, Elena Meshcheriakova, Vanessa Nolasco, Rebecca Addo 1. Deakin University

Harvard University international health care costs study In collaboration with the Harvard T.H. Chan School of Public Health and the Commonwealth Fund, this project will contribute the Australian data and analysis to enable an international comparison of health care costs for high-need patients. This collaboration includes up to the 11 countries including Canada, France, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland, the United Kingdom, and the United States. Funding source: The Commonwealth Fund, New York Investigators: Kees van Gool, Jane Hall, Olukorede Abiona, Chunzhou Mu, Tom Longden, Patsy Kenny Preparation of briefing papers for End of Life Directions for Aged Care (ELDAC)

The aim of this project is to prepare some ‘briefing papers’ centred on how palliative care needs are identified and funded in residential care and community-based aged care. Funding source: Palliative Care Australia Investigators: Mike Woods, Kees van Gool The impact of the new Indigenous Australians’ Health Program Funding The aim of this project is to develop a funding model that estimates the financial implications on Aboriginal Medical Services (AMSs) if the new funding model (as proposed by the Australian Department of Health) were to be implemented. The model will generate a range of financial outputs for different types of AMSs – based on their key characteristics such as dispersal, need and capabilities.

Funding source: Aboriginal Health and

Medical Research Council (AH&MRC)

Investigators: Kees van Gool, Mike Woods,

Phil Haywood


NEW PEER REVIEWED GRANTS in 2017/2018

A Randomised Phase III Study of the duration of the Anti-PD1 - therapy in metastatic melanoma (STOP-GAP)

In this trial, it is hypothesized that interrupting anti-PD-1 therapy in patients with metastatic melanoma after maximum tumour response (MTR) is non-inferior in overall survival or progression-free survival compared to continuous treatment for up to 24 months. It is anticipated that interrupted dosing will result in less treatment toxicity, improved quality of life (QOL) and decreased costs of treatment. Based on feasibility studies, at least 20 ANZ centres will contribute 400 patients to the total / 3 years + 2 years follow up, with the remainder of patients from Canada. If STOP-GAP supports interrupted dosing, this would have wide implications given emerging use of PD-1 based therapy for other cancers.

Investigators: Victoria Atkinson1, Matteo Carlino2, Janet Dancey3, Rosalie Viney, Madeleine King4, Serigne Lo5, Naomi van der Linden

1. Queensland Health 2. Westmead Hospital 3. Ontario Institute for Cancer Research, Toronto, Canada 4. University of Sydney 5. Melanoma Institute Australia

The Strong Families Trial: Randomised controlled trial of a family strengthening program to prevent unhealthy weight gain among 5- to 11-year old children from at risk families

This project aims to test whether an 8-week behavioural parenting and lifestyle (BPL) intervention (+2 boosters) for parents and carers of 5-11 year old children is effective, sustainable and cost-effective in improving children’s anthropometric outcomes and family functioning. This family-centred intervention has the potential to reduce obesity through improved family functioning in relation to eating and physical activity patterns in children in disadvantaged and multi-ethnic populations. Cost-effective programs are urgently needed to reduce childhood obesity and its inequalities among ‘at-risk’ populations.

Funding source: NHMRC Project Grant Investigators: Andre Renzaho1, Chris Rissel2, Louise Baur2, Timothy Gill2, Julie Green3, Md Billah4, Paula Cronin

1. University of Western Sydney 2. University of Sydney 3. Murdoch Children’s Research Institute 4. Monash University

A multi stage multi centre international randomised trial of Conventional care Or Radioablation (stereotactic body radiotherapy) for Extra-cranial oligometastatic disease in lung, breast and prostate cancer (CORE)

This project aims to determine whether the addition of ablative Stereotactic Body Radiotherapy (to standard of care) improves progression free survival (PFS) in patients with a limited burden of metastatic disease and whether phase III trials of Stereotactic Body Radiotherapy (SBRT) for lung, breast and/or prostate cancer patients with oligometastatic disease feasible. CHERE will be conducting an economic evaluation alongside this trial.

Funding source: Cancer Australia Investigators: Farshad Foroudi1, Daryl Lim Joon2, Michael Millward3, Fiona Hegi-Johnson, Marion Haas 1. Austin Health 2. University of Melbourne 3. University of Western Australia 4. Peter MacCallum Cancer Centre, Melbourne

The proPSMA study (A prospective multicentre study of the impact of Ga-68 PSMA-PET/CT imaging for staging high risk prostate cancer prior to curative-intent surgery or radiotherapy)

This clinical trial will investigate a new type of scan which provides whole body images of prostate cancer spread. Early experience suggests that this new technology, called PSMA PET/CT (prostate specific membrane antigen positron emission tomography/computed tomography), is superior to current scanning techniques. PSMA PET/CT has capacity for wide availability at relatively low cost. Performing a single better test rather than several less accurate scans will also be cheaper, improve patient experience and expose patients to lower amounts of radiation. A health economic analysis will be performed.

Funding source: Prostate Cancer Foundation of Australia Investigators: Michael Hofman1, Scott Williams1, Nathan Lawrentschuk1, Roslyn Francis2, Jarad Martin3, Paul Roach4, Mark Frydenberg5, Paul Thomas6, Richard De Abreu Lourenço


1. Peter MacCallum Cancer Centre 2. Sir Charles Gairdner Hospital, Perth WA 3. Calvary Mater Hospital, Newcastle 4. University of Sydney 5. Monash University 6. Royal Brisbane & Women's Hospital

Australian Predicting Infectious ComplicatioNs In Children with Cancer (PICNICC) project

This study will test and modify rules that can identify children at low risk of having complications of fever and neutropenia after cancer chemotherapy and who will be eligible for early discharge and outpatient treatment. Immune function blood tests will also be assessed to see if they add value to the rule which is based on patient factors.

Funding source: NHMRC Project Grant Investigators: Karin Thursky1, Robert Phillips2, Franz Babl3, Monica Slavin1, Mechinaud Heloury3, Gabrielle Haeusler4, Richard De Abreu Lourenço

1. Melbourne Health 2. University of York, UK 3. Royal Children's Hospital Melbourne 4. Peter MacCallum Cancer Centre

Counting the Cost of Curing Childhood ALL by Transplantation

The primary aim of this project is to see if the life-long consequences of children with acute lymphoblastic leukaemia (ALL) receiving total body irradiation (TBI) as part of Bone Marrow Transplant (BMT) can be eliminated. BMT cures patients, but if done using TBI, has life-long consequences, such as cancers and heart disease. In this unique study the investigators in Australia will join a worldwide group to see if they can stop using TBI in these children and reduce the long burden of therapy (FORUM).The costs of the whole BMT procedure will be measured together with outcome data, then the cost-effectiveness of chemotherapy compared with TBI will be assessed, to allow better allocation of health care resources in the treatment of children with ALL.

Funding source: Cancer Australia Investigators: Peter Shaw1, Tracey O’Brien2, Melissa Gabriel2, Richard De Abreu Lourenço, Marion Haas

1. University of Sydney 2. Kids Cancer Centre, Sydney Children’s Hospital

Markov Modelling versus Partitioned Survival Modelling to determine the real-world cost-effectiveness of oncology drugs

This study aims to determine and document the extent of use of Partitioned Survival Models (PSM) and Markov Cohort Models (MCM) in submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) over the last 10 years, including whether this differs across different diseases and drug categories, determine factors that drive the choice for PSM or MCM, and any advantages and disadvantages identified. It will also investigate whether PSM can be used to synthesise evidence from randomised and observational sources to determine the RW cost-effectiveness of an oncology medicine and compare the feasibility and results of such an approach with MCM.

Funding source: NHMRC Centre for Research Excellence in Polypharmacy Investigators: Naomi van der Linden, Stephen Goodall, Sallie Pearson1


Risks And Imminent Danger: an analysis of the endogeneity between high-risk prescribing, potentially preventable hospitalisations, age and time to death (RAID)

This project aims to compare the amplifications of adverse outcomes (such as increased hospital costs and length of stay) across multiple risk/danger scenarios. This comparison will be conducted using the switching model estimates from nine high risk/danger scenarios that are calculated in relation to a low risk/danger base case. As these estimates are adjusted for age and mortality, they will allow for an assessment of whether high-risk prescribing and/or potentially preventable hospitalisations are causing adverse outcomes that are potentially mitigatable.

Funding source: NHMRC Centre for Research Excellence in Polypharmacy Investigators: Tom Longden, Rosalie Viney, Kees van Gool, Sallie Pearson1.



Evaluating a shared care pathway intervention to reduce chemotherapy outpatients’ unplanned presentations to hospital (ESCAPI) The aim of this project is to determine if this intervention is effective in reducing the number of unplanned presentations to hospital by chemotherapy outpatients; improving the physical and psychosocial health outcomes (quality of life) for these patients; and to quantify costs and outcomes associated with this class of intervention and evaluate its cost effectiveness. Funding source: NHMRC Project Grant Investigators: Kate White1, Heather McKenzie1, Lillian Hayes1, Judy Simpson1, Lisa Horvath1, Simon Willcock1, Judith Fethney1, Richard De Abreu Lourenço, Marion Haas 1. University of Sydney

Reassessing findings of a net benefit of climate change that were based on cold weather biased temperature-mortality relationships

This project will confirm whether previous studies of the impact of climate change on temperature-related deaths have been biased towards cold-related mortality.

Funding source: UTS Business Research Grant Scheme Investigators: Thomas Longden

Residential aged care funding in Australia: Who gets what?

The overall objective of this project is to generate significant new insights into individual level funding of the elderly in residential aged care by taking advantage of the release of longitudinal, survey-linked, Commonwealth administrative data on aged care services.

Funding source: UTS Business Research Grant Scheme Investigators: Serena Yu

The aged care sector has undergone substantial reforms over recent years but our understanding of its impact remains limited. The overall objective of the project is to generate important new insights into the effect of residential aged on healthcare and aged care service use and costs. The research will take advantage of the release of longitudinal, survey-linked, Commonwealth administrative data on aged care services.

Using this newly available data, this project aims to address the following questions:

1. What are the individual-level public costs of providing residential aged care services? 2. How do these costs interact with the cost of providing health care? 3. How do these costs vary for eligible individuals who take up residential aged care versus those who remain in their communities?

Funding source: UTS Research Re-establishment Grant Investigators: Serena Yu


ACHIEVEMENTS

Dr Richard De Abreu Lourenço

Richard is the recipient of a prestigious Chancellor’s Research Fellowship examining the Value of choice in Cancer care (VOCCE).

Dr Paula Cronin had her PhD conferred in March 2018. She graduated in May 2018.

JOURNAL EDITORSHIPS

Prof Rosalie Viney is an Associate editor of Health Economics

Prof Debbie Street is an Associate Editor of the Australian and New Zealand Journal of Statistics

Dr Richard De Abreu Lourenço is an Associate editor of Health Policy

Dr Alison Pearce is an editorial board member of PharmacoEconomics Open

Dr Michael Wright is on the Editorial Advisory Board for the Australian Journal of General Practice

COMMITTEE MEMBERSHIPS

Prof Rosalie Viney

Member of EuroQOL

Member of EuroQOL Valuation Working Group

Member of NHMRC Research Committee

Chair, NHMRC Women in Health Science

Committee

Prof Jane Hall Board of the Bureau of Health Information Member of the Independent Hospital Pricing

Authority (IPHA) Life Saving Drugs Program Reference Group. Review established by Commonwealth Department of Health Primary Health Care Research, Evaluation and Development Strategy Advisory Committee

Prof Stephen Goodall President of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Australian Chapter UTS Ethics Committee – Clinical Trials sub-committee Editorial Board of the Health Technology Assessment (HTA) Glossary Food Standards Australia New ZeaKiland Fellow

A/Prof Kees van Gool Advisory Committee for the Australian Institute of Health and Welfare’s (AIHW) Report on Out-of-pocket costs of non-hospital Medicare services

Dr Richard De Abreu Lourenço Trans Tasman Radiation Oncology Group Scientific Advisory Committee Trans Tasman Radiation Oncology Group Secondary Data Analysis Committee

Dr Paula Cronin Member of MSAC Economic Subcommittee

Dr Phil Haywood Protocol Advisory Sub-committee of the Medical Services Advisory Committee (MSAC) Health Science Alliance (HSA) Biobank Research Access Committee

Dr Alison Pearce UTS Research Sub-Committee of the Academic Board Dr Michael Wright Royal Australian College of General Practitioners (RACGP) NSW/ACT Faculty Board Boards of Directors, Central and Eastern Sydney Primary Health Network

Brendan Mulhern Member of EuroQol Group Member of EuroQol Descriptive System Working Group Communications and Outreach committee member of ISPOR Australia Member of eQALY international advisory group


Sopany Saing Student Member of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Australian Chapter

VISITORS TO CHERE

Professor Tom Buchmueller, University of Michigan, USA

Elizabeth Lemmon, University of Stirling, Scotland

Qinglu Cheng, Queensland University of Technology

Marjon Faaij, Utrecht University, The Netherlands

Thomas van Gelder, Utrecht University, The Netherlands

VISITING SPEAKERS

Professor Philip Clarke, University of Melbourne Topic: Health economic evaluation through the ages

Professor Tom Buchmueller, University of Michigan, USA Topic: The effect of organised breast screening on mammography use: Evidence from France

Professor James Rockey, University of Bristol Topic: The wounds that don't heal the lifetime scar of youth unemployment

Ms Kerri Kellett, Health Systems Policy Division, Commonwealth Department of Health Topic: How to make research more accessible to policy makers: Understanding the policy environment and how to make research more accessible to policy makers – an insider’s perspective

Professor Brenda Gannon, Centre for the Business and Economics of Health, The University of Queensland Topic: The impact of cognitive impairment on health care

NEW STAFF

Constanza Vargas Constanza joined CHERE as a Research Fellow in October 2017. She has a background in pharmaceutical science and a Master’s degree in Health Economics, from the University of Queensland. Prior to joining CHERE, Constanza worked as a research coordinator in the Health Technology Assessment Unit of the Clinical Research Centre at the Pontificia Universidad Catolica in Santiago, Chile. She has experience in the development and adaptations of economic evaluations to support decision making, teaching post graduate courses in fundamentals of health economics and economic evaluations, critical appraisal of clinical evidence and the writing of scientific articles. Since joining CHERE she has reviewed and conducted evaluations for the Pharmaceutical Benefits Advisory Committee (PBAC).

Dr Olukorede Abiona is a Research Fellow in Applied Health Economics at CHERE – he started at CHERE in October 2017. Prior to joining CHERE, Olukorede worked as an assistant lecturer at the University of Leicester where he earned his PhD in Development Economics. He also held part-time teaching positions at the University of Leicester during his PhD. Olukorede is an applied microeconomist and his research interests lie in the application of econometrics methods for impact evaluation of policies. His research areas cover health economics and development economics. He is currently working on the impact of aged care policies on payment choices of residents and the impact of the Medicare Benefits Schedule (MBS) caps on specialist fees.

Dr Margie Campbell joined the Centre for Health Economics Research Evaluation (CHERE) as a Research Fellow in January 2018. She is currently completing a Graduate Diploma in Health Economics and Policy. Margie started her scientific career with a Ph.D. in Biochemistry followed by several post-doctoral research positions including at the US National Institutes of Health (NIH). During this time, she trained and managed a team of researchers, was a recipient of NHMRC and Arthritis Foundation Project Grants and was a presenter at national and global scientific meetings.


Margie has worked in a number of stakeholder and project management roles in leading pharmaceutical and medical device companies in clinical research, regulatory affairs, medical affairs, corporate compliance and in the not-for-profit sector.

At CHERE, Margie is the Project Manager on

the Victorian Healthy Homes Program and a

researcher on the Evaluation Team for the

Crusted Scabies Project.

Kittiphong Thiboonboon is a Research

Fellow at CHERE – he started in February

2018. His main responsibility is to provide

critical appraisals for economic evaluations

submitted to the Pharmaceutical Benefits

Advisory Committee (PBAC). His main interest

is using economic evaluation methods to

support policymakers in the health care sector.

He is experienced in modelling to evaluate the

cost-effectiveness of health interventions and

in performing systematic reviews. Prior to

joining CHERE he was a researcher at the

Health Intervention and Technology

Assessment Program (HITAP) in Thailand

where he provided technical assistance for

projects in low- and middle-income countries,

including health technology assessment,

capacity strengthening and economic

evaluation methodology research. He has a

Bachelor’s degree in economics from

Srinakharinwirot University, Thailand, and a

Master’s degree in health economics from the

University of York.

Milena Lewandowska joined CHERE as a Research Fellow in February 2018. She completed her Master of Health Economics at the University of Oslo. Prior to joining CHERE, Milena worked at MSD Norway, (a pharmaceutical R&D company), in the Policy and Communication group. Milena has held various roles in the Norwegian healthcare sector, both in the public and private sectors. Milena has worked on a range of different projects including development and adaptations of economic evaluations to support decision making, Health Technology Assessment of medical devices and surgical procedures as well development and implementation of eHealth initiatives. At CHERE Milena is a member of the Economic Evaluation team completing evaluations for the Pharmaceutical Benefits Advisory Committee (PBAC).

Oona Reardon is employed as a Research Fellow with the Centre for Health Economics Research and Evaluation. She started in <She is part of the PBAC Evaluation Team and Cancer Research Economics Support Team (CREST). She has extensive experience in regulatory affairs within the pharmaceutical industry including the development of complex regulatory strategies for drug reformulation and split dosing. She has registered many new medicines with the TGA and Medsafe. Prior to joining the pharmaceutical industry, Oona worked as a Medical Physicist for several years at Liverpool Hospital’s Cancer Therapy Centre (CTC) and the PET and Nuclear Medicine Department, Royal Price Alfred Hospital (RPAH). During the last year, Oona has worked on MSAC Assessment Reports and critiques. She is currently studying a Master’s Degree in Health Economics.

Qualifications: BSc (Hons) Applied Physics (UTS), Dip Scientific Practice (UTS)

CURRENT PHD STUDENTS

Rebecca Addo PhD Topic: The Feasibility of Health Technology Assessment (HTA) in the Ghanaian Health System. Assessing the knowledge and attitudes of decision makers and researchers towards HTA in Ghana Supervisors: Prof Jane Hall, Prof Marion Haas, Prof Stephen Goodall

Sheena Arora PhD Topic: Economic evaluation of an intervention in parents with children who have developmental disabilities Supervisors: Prof Stephen Goodall, Prof Rosalie Viney, Prof Stewart Einfeld1 1. University of Sydney

Jody Church PhD Topic: Economics of Obesity Supervisors: Prof Stephen Goodall, Prof Marion Haas, A/Prof Kees van Gool

Paula Cronin (Graduated May 2018) PhD Topic: Measuring the social and economic impact of communication disorders in Australia Supervisors: Prof Stephen Goodall, Dr Tricia McCabe1, Prof Rosalie Viney, Dr Rebecca Reeve2

1. University of Sydney 2. UNSW


Siobhan Dickinson PhD Topic: Out-of-Pocket healthcare costs in Australia Supervisors: A/Prof Kees van Gool, Prof Jane Hall

Dr Philip Haywood PhD Topic: An outcome based reimbursement scheme for cancer pharmaceuticals Supervisors: Prof Marion Haas, Prof Rosalie Viney

Kathleen Manipis PHD Topic: The economic cost of foodborne illness to Australia Supervisors: Prof Stephen Goodall, Dr Alison Pearce

Elena Meshcheriakova PhD Topic: Evaluation of the methods and techniques in the design of discrete choice experiments used to measure consumer preferences Supervisors: Prof Stephen Goodall, Prof Rosalie Viney, Prof Deborah Street

Brendan Mulhern PhD Topic: Testing and advancing the methods used to develop and value preference based measures for use in economic evaluation Supervisors: Prof Rosalie Viney, Prof Debbie Street, Prof John Brazier1 1. University of Sheffield

Ros Prichard PhD Topic: The cost effectiveness of advanced heart failure management and mechanical circulatory assist therapy Supervisors: Prof Stephen Goodall, Trish Davidson1, Chris Hayward2 1. Graduate School of Health, UTS 2. St Vincent’s Hospital

Mohammad Pulok PhD Topic: Measuring equity of access to health care in Australia: Evidence from administrative and survey data Supervisors: Prof Jane Hall and A/Prof Kees van Gool Funding: UTS International Research Scholarship and CMCRC PhD scholarship Industry partner: National Health Performance Authority (NHPA)

Sopany Saing PhD Topic: Testing and advancing the methods used to develop and value preference based measures for use in economic evaluation

Supervisors: Prof Stephen Goodall, Dr Naomi van der Linden, Prof Christopher Hayward1 1. St Vincent's Hospital

Dr Michael Wright PhD Topic: 21st Century Continuity of Care - Understanding Person and Place Based Continuity in Australian General Practice Supervisors: Prof Jane Hall, A/ Prof Kees van Gool, Prof Marion Haas

Jackie Yim PhD Topic: Health economics of anxiety and depression in cancer patients Supervisors: Rosalie Viney, Dr Alison Pearce

Alice Yu PhD Topic: The impact of design factors on preferences made in Discrete Choice Experiments Supervisors: Prof Deborah Street, Prof Rosalie Viney, Prof Stephen Goodall

PEER-REVIEWED PUBLICATIONS 2018

Arora, S., Goodall, S., Viney, R. & Einfeld, S. 2018, 'Using discrete choice experiment methods to estimate the value of informal care: the case of children with intellectual disability', PharmacoEconomics, forthcoming.

Cole, A., Shah, K., Mulhern, B., Feng, Y. & Devlin, N. 2018, 'Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment', European Journal of Health Economics, vol. 19, no. 4, pp. 595-605.

Comans, T.A., Nguyen, K.-.H., Mulhern, B., Corlis, M., Li, L., Welch, A., Kurrle, S.E., Rowen, D., Moyle, W., Kularatna, S. & Ratcliffe, J. 2018, 'Developing a dementia-specific preference--based quality of life measure (AD-5D) in Australia: a valuation study protocol.', BMJ Open, vol. 8, no. 1, p. e018996.

Devlin, N., Feng, Y., Shah, K., Mulhern, B. & van Hout, B. 2018, 'Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England', Health Economics, vol. 27, no. 1, pp. 7-22.

Feng, Y., Devlin, N., Shah, K., Mulhern, B. & van Hout, B. 2018, 'New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data', Health Economics, vol. 27, no. 1, pp. 23-38.


Gamper, E., Kemmler, G., Holzner, B., Norman, R., King, M. & Viney, R.C. 2018, 'Test-retest reliability of discrete choice experiment for valuations of QLU-C10D health states', Value in Health, forthcoming.

Gardner, T., Refshauge, K., McAuley, J., Hübscher, M., Goodall, S. & Smith, L. 2018, 'Goal setting practice in chronic low back pain. What is current practice and is it affected by beliefs and attitudes?', Physiotherapy Theory and Practice, forthcoming.

Haeusler, G.M., Thursky, K.M., Slavin, M., Mechinaud, F., Babl, F.E., Bryant, P., De Abreu Lourenço, R. & Phillips, R. 2018, 'External validation of six pediatric fever and neutropenia clinical decision rules', Pediatric Infectious Disease Journal, vol.37 no.4 pp. 329-335.

Hewitt, J., Goodall, S., Clemson, L., Henwood, T. & Refshauge, K. 2018, 'Progressive resistance and balance training for falls prevention in long term residential aged care: A cluster randomized trial of the Sunbeam Program', Journal of the American Medical Directors Association (JAMDA), vol. 19, no. 4, pp. 361-369.

Hofman, M.S., Murphy, D.G., Williams, S.G., Nzenza, T., Herschtal, A., De Abreu Lourenço, R., Bailey, D.L., Budd, R., Hicks, R.J., Francis, R.J. & Lawrentschuk, N. 2018, 'A prospective randomised multi-centre study of the impact of Ga-68 PSMA-PET/CT imaging for staging high risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol', BJU International, forthcoming.

Kasparian, N., De Abreu Lourenço, R., Winlaw, D.S., Sholler, D.F., Viney, R. & Kirk, E.P.E. 2018, 'Tell me once, tell me soon: Parents’ preferences for clinical genetics services for congenital heart disease', Genetics in Medicine, forthcoming.

Keighley, T., Longden, T., Mathew, S. & Trück, S. 2018, 'Quantifying catastrophic and climate impacted hazards based on local expert opinions', Journal of Environmental Management, vol. 205, pp. 262-273.

King, M., Viney, R.C., Pickard, S., Rowen, D., Aaronson, N.K., Brazier, J.E., Cella, D., Costa, D.S.J., Fayers, P., Kemmler, G., McTaggart-Cowen, H., Mercieca-Bebber, R., Peacock, S., Street, D.J., Young, T.A. & Norman, R. 2018, 'Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument

derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30', PharmacoEconomics, vol. 36, no. 2, pp. 225-238.

Longden, T., Hall, J. & Van Gool, K. 2018, 'Supplier-induced demand for urgent after-hours primary care services', Health Economics, forthcoming.

Mulhern, B., Feng, Y., Shah, K., Janssen, B., Herdman, M., van Hout, B. & Devlin, N. 2018, 'Comparing the UK EQ-5D-3L and English EQ-5D-5L value sets: Implications for NICE decision making', PharmacoEconomics, forthcoming.

Mulhern, B., Norman, R., Shah, K., Bansback, N., Longworth, L. & Viney, R. 2018, 'How should DCE with duration choice sets be presented for the valuation of health states?', Medical Decision Making, vol 38, no.3, pp. 306-318.

Oliver, D. & Yu, S. 2018, 'The Australian labour market in 2017', Journal of Industrial Relations, forthcoming.

Pearce, A.M., Sharp, L., Hanly, P., Barchuk, A., Bray, F., de Camargo Cancela, M., Gupta, P., Meheus, F., Qiao, Y.L., Sitas, F., Wang, S.M. & Soerjomataram, I. 2018, 'Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China, and South Africa (BRICS): A population-based comparison', Cancer Epidemiology, vol. 53, pp. 27-34.

Prichard, R., Hayward, C., Davidson, P., Newton, P., Goodall, S. & Kershaw, L. 2018, 'Left ventricular device implantation impacts on hospitalisation rates, length of stay and out of hospital time', Heart, Lung and Circulation, vol. 27, no. 6, pp. 708-715.

Rowan, D., Labeit, A., Stevens, K., Mulhern, B., Elliot, J., Basarir, H., Ratcliffe, J. & Brazier, J. 2018, 'Using a discrete choice experiment involving cost to value a classification system measuring the quality of life impact of self-management for diabetes', Value in Health, vol. 21, no. 1, pp. 69-77.

Rowen, D., Mulhern, B.J., Vermaire, E. & Stevens, K. 2018, 'Estimating a Dutch value set for the paediatric preference-based CHU-9D using a discrete choice experiment with duration', Value in Health, forthcoming.

Saing, S., Haywood, P., Duncan, J., Ma, N., Cameron, A. & Goodall, S. 2018, 'Cost-effective imaging for resectability of liver


lesions in colorectal cancer: An economic decision model', ANZ Journal of Surgery, forthcoming.

Saing, S., Parkinson, B., Church, J. & Goodall, S. 2018, 'Cost effectiveness of a community delivered consultation to improve infant sleep problems and maternal well-being', vol. Value in Health Regional Issues, vol. 15 pp. 91-98.

Street, D. & Bird, E. 2018, 'D-optimal orthogonal array minus t run designs', Journal of Statistical Theory and Practice, forthcoming.

van der Linden, M.C., de Beaufort, R.A.Y., Meylaerts, S.A.G., van den Brand, C.L. & van der Linden, N. 2018, 'The impact of medical specialist staffing on emergency department patient flow and satisfaction', European Journal of Emergency Medicine, forthcoming.

Van Der Linden, M.C., Rambach, A.A.H. & Van Der Linden, N. 2018, 'Case report: A patient with malaria at the emergency department', International Emergency Nursing, vol. 36, pp. 63-66.

van der Linden, M.C., van den Brand, C., van den Wijngaard, I.R., de Beaufort, R.A.Y., Van Der Linden, N. & Jellema, K. 2018, 'A dedicated neurologist at the emergency

department during out‑of‑office hours

decreases patients’ length of stay and admission percentages', Journal of Neurology, vol. 265 no. 3 pp. 535-541.

van der Linden, M. C.; van Loon, M.; Feenstra, N. S. F.; Van Der Linden, N. 2018, ‘Assessing bottlenecks in Emergency Department flow of patients with abdominal pain’, International Emergency Nursing, forthcoming.

Wong, C. & Hall, J. 2018, 'Does patients’ experience of general practice affect the use of emergency departments? Evidence from Australia', Health Policy, vol. 122, no. 2, pp. 126-133.

Wright, M.C., Hall, J., Van Gool, K. & Haas, M. 2018, 'How common is multiple general practice attendance in Australia?', Australian Journal of General Practice, vol 47, no. 5, pp. 289-296.

Yu, S., & Peetz, D. (2018). Nonstandard time wage premiums and employment effects: Evidence from an Australian natural experiment. British Journal of Industrial Relations, forthcoming.

Yu, S., van Gool, K., Kirby, S., Gardner, K., Robinson, L., Linehan, T., Harris, M.F. & Hall, J. 2018, 'The business of integrated care: implementing new models of care in a fee-for-service setting', Journal of Integrated Care, vol. 26 no. 1 pp. 16-28.

BOOK CHAPTERS 2018

Viney, R.C., Hall, J., Duckett, S. & Moran, S. 2018, 'Health economics' in The future of precision medicine in Australia, Australian Council of Learned Academies (ACOLA), Melbourne, pp. 100-113.

Woods, M.C. 2018, 'Projecting long-term fiscal outcomes' in Podger, A., Su, T.-.T., Wanna, J., Chan, H.S. & Niu, M. (eds), Value for money: Budget and financial management reform in the People's Republic of China, Taiwan and Australia, ANU Press, Canberra, pp. 43-63.

REPORTS 2018

Lemmon, E., Woods, M., van Gool, K. 2018. Palliative care in residential care: Identifying and funding palliative care needs in Australia, CHERE, Sydney.

Lemmon, E., Woods, M., van Gool, K. 2018. Palliative care in community care: Identifying and funding palliative care needs in Australia, CHERE, Sydney.

CONFERENCE PRESENTATIONS 2018

Hall, J.P. 2018, 'Improving the performance of Australia's health system [invited]', 8th National Health Reform Summit: 'Equity Efficinency and Sustainability', Canberra.

Pulok, M ‘Horizontal equity in the Australian healthcare system’, Canadian Centre for Health Economics Series, University of Toronto, Canada

Woods, M.C. 2018, 'Australia’s Key Aged Care Reforms', Aged Care Finance Symposium, Adelaide.

Woods, M.C. 2018, 'Health Workforce Accreditation', National Professional


Accreditation Best Practices Summit, Melbourne.

Woods, M.C. 2018, 'Health workforce Future Fundamentals', Universities Australia Higher Education Conference, Canberra.

PEER-REVIEWED PUBLICATIONS 2017

Agar, M., Luckett, T., Luscombe, G., Phillips, J., Beattie, E., Pond, D., Mitchell, G., Davidson, P., Cook, J., Brooks, D., Houltram, J., Goodall, S. & Chenoweth, L. 2017, 'Effects of facilitated family case conferencing for advanced dementia: A cluster randomised clinical trial', PLoS ONE, vol. 12, no. 8, pp. e0181020-e0181020.

Cronin, P.A., Kirkbidge, B., Bang, A., Smith, D., Parkinson, B. & Haywood, P. 2017, 'Long-term health care costs for patients with prostate cancer: A population-wide longitudinal study in New South Wales Australia', Asia Pacific Journal of Clinical Oncology, vol. 13, no. 3, pp. 160-171.

Cronin, P.A., Reeve, R., Viney, R., McCabe, P. & Goodall, S. 2017, 'The impact of childhood language difficulties on healthcare costs from 4 to 13 years: Australian longitudinal study', International Journal of Speech-Language Pathology, vol. 19, pp. 381-391.

Gardner, T., Refshauge, K., McAuley, J., Hübscher, M., Goodall, S. & Smith, L. 2017, 'Physiotherapists' beliefs and attitudes influence clinical practice in chronic low back pain: a systematic review of quantitative and qualitative studies', Journal of Physiotherapy, vol. 63, no. 3, pp. 132-143.

Haeusler, G., Thursky, K., Mechinaud, F., Babl, F., De Abreu Lourenço, R., Slavin, M. & Phillips, B. 2017, 'Predicting Infectious ComplicatioNs In Children with Cancer: an external validation study', British Journal of Cancer, vol. 117, no. 2, pp. 171-178.

Hanly, P., Pearce, A. & Sharp, L. 2017, 'Cancer and productivity loss in the Irish economy: an employer’s perspective', The Irish Journal of Management, vol. 36, no. 1, pp. 5-20.

Jefford, M., Emery, J., Grunfeld, E., Martin, A., Rodger, P., Murray, A., De Abreu Lourenço,

R., Heriot, A., Phipps-Nelson, J., Guccione, L., King, D., Lisy, K., Tebbutt, N., Burgess, A., Faragher, I., Woods, R. & Schofield, P. 2017, 'SCORE: Shared care of colorectal cancer survivors: study protocol for a randomised controlled trial', Trials, vol. 18, no. 506.

Kanters, T.A., Bouwmans, C.A.M., van der Linden, N., Tan, S.S. & Hakkaart-van Roijen, L. 2017, 'Update of the Dutch manual for costing studies in health care.', PloS One, vol. 12, no. 11, p. e0187477.

Kenny, P.M., Goodall, S., Street, D. & Greene, J. 2017, 'Choosing a Doctor: Does presentation format affect the way consumers use health care performance information?', The Patient: Patient Centered Outcomes Research, vol. 10, no. 6, pp. 739-751.

Luckett, T., Chenoweth, L., Phillips, J., Brooks, D., Cook, J., Mitchell, G., Pond, D., Davidson, P., Beattie, E., Luscombe, G., Goodall, S., Fischer, T. & Agar, M. 2017, 'A facilitated approach to family case conferencing for people with advanced dementia living in nursing homes: Perceptions of Palliative Care Planning Coordinators and other health professionals in the IDEAL Study', International Psychogeriatrics, vol. 29, pp. 1713-1722.

McRae, I., Van Gool, K., Hall, J. & Yen, L. 2017, 'The role of cost on failure to access prescribed pharmaceuticals – the case of statins', Applied Health Economics and Health Policy, vol. 15, no. 5, pp. 625-634.

Mu, C., De Abreu Lourenço, R., van Gool, K. & Hall, J. 2017, 'Is low priced primary care bad for quality? Evidence from Australian general practice', Applied Economics, vol. 50, no. 5, pp. 475-491.

Mulhern, B., Labeit, A., Rowen, D., Knowles, E., Meadows, K., Elliott, J. & Brazier, J. 2017, 'Developing preference-based measures for diabetes: DHP-3D and DHP-5D', Diabetic Medicine, vol. 34, no. 9, pp. 1264-1275-1264-1275.

Nerich, V., Saing, S., Gamper, E.-.M., Holzner, B., Pivot, X., Viney, R. & Kemmler, G. 2017, 'Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses.', Breast Cancer Research and Treatment, vol. 164, no. 3, pp. 527-536.

Oliver, D. & Yu, S. 2017, 'The Australian labour market in 2016', Journal of Industrial Relations, vol. 59, no. 3, pp. 254-270.


Pearce, A.M., Haas, M., Viney, R., Pearson, S-A., Haywood, P., Brown, C. & Ward, R. 2017, 'Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study', PLoS ONE, vol. 12, no. 10.

Shah, K., Mulhern, B., Longworth, L. & Janssen, M.F. 2017, 'Views of the UK general public on important aspects of health not captured by EQ-5D', The Patient: Patient Centered Outcomes Research, vol. 10, no. 6, pp. 701-709.

Stolk, E.A., Craig, B.M., Mulhern, B. & Brown, D.S. 2017, 'Health Valuation: Demonstrating the Value of Health and Lifespan.', The Patient, vol. 10, no. 4, pp. 515-517.

Thomas, A.A., Pearce, A., O'Neill, C., Molcho, M. & Sharp, L. 2017, 'Urban–rural differences in cancer-directed surgery and survival of patients with non-small cell lung cancer', Journal of Epidemiology and Community Health, vol. 71, no. 5, pp. 468-474.

Van Breeschoten, J., De Abreu Lourenço, R., Signorelli, C., Haas, M., Cohn, R.J., Wakefield, C.E. & Fardell, J.E. 2017, 'Patterns and drivers of health care use in long-term childhood cancer survivors: a systematic review', Critical Reviews in Oncology/Hematology, vol. 220, pp. 60-76.

van der Linden, M.C., Khursheed, M., Hooda, K., Pines, J. & van der Linden, N. 2017, 'Two emergency departments, 6000 kilometers apart: differences in patient flow and staff perceptions about crowding', International Emergency Nursing, vol. 35, pp. 30-36.

Wong, C., Greene, J., Dolja-Gore, X. & van Gool, K. 2017, 'The rise and fall in out-of-pocket costs in Australia: An analysis of the Strengthening Medicare Reforms', Health Economics, vol. 26, no. 8, pp. 962-979.

BOOK CHAPTERS 2017

Carraro, C., Tavoni, M., Longden, T. & Marangoni, G. 2017, 'The Potential Role of Gas in Decarbonizing Europe: A Quantitative Assessment' in Hafner, M. & Tagliapietra, S. (eds), The European Gas Markets: Challenges and Opportunities, Springer International Publishing, Cham, pp. 25-48.

Hall, J.P. & Van Gool, K. 2017, 'Improving the productivity of health services' in Improving

service sector productivity: the economic imperative, Committee for Economic Development of Australia (CEDA), Melbourne, pp. 35-46.

CONFERENCE PRESENATIONS 2017

Addo, R., Hall, J., Goodall, S. & Haas, M. 2017, 'The knowledge and perception of Ghanaian decision makers and researchers towards the use of health technology assessment for health decision making', iHEA Boston World Congress, Boston, USA.

Addo, R., Hall, J.P., Haas, M. & Goodall, S. 2017, 'Using Economic Evidence to Set Priorities in Ghana: The Case of Malaria', Health Technology Assessment International Annual Meeting, Rome.

Arora, S., Goodall, S., Viney, R. & Einfeld, S. 2017, 'The health-related quality of life of caregivers of children with intellectual disability', 39th Annual Australian Health Economics Society Conference, Sydney.

Brazier, J. & Mulhern, B. 2017, 'Utility measures - Short Course', International Society for Pharmacoeconomics and Outcomes Research 22nd Annual International Meeting, Boston, USA.

Cronin, P.A., Reeve, R., Goodall, S., Viney, R. & McCabe, P. 2017, 'Labor market participation for caregiving mothers of children with language impairment', iHEA Boston World Congress, Boston, USA.

De Abreu Lourenço, R. 2017, 'Assessing the cost-effectiveness of immunotherapy: Do modern drugs need modern methods?', Clinical Oncology Society of Australia (COSA) Annual Scientific Meeting, Perth.

De Abreu Lourenço, R. 2017, 'Does one size fit all? Determining value of prostate cancer and urology care', ANZUP Annual Scientific Meeting, Melbourne.

De Abreu Lourenço, R. 2017, 'One in, all in: Involving patients in research', The Time is Now, University of Technology Sydney.

Fiebig, D., Van Gool, K., Hall, J. & Yu, S. 2017, 'Provider moral hazard and insurance


eligibility: The case of Australia’s Medicare safety net program', iHEA Boston World Congress, Boston, USA.

Flattery, M., Mulhern, B., Norman, R., Viney, R., Street, D., Feng, Y., Addo, R., Manipis, K., Meshcheriakova, E. & Saing, S. 2017, 'Valuing EQ-5D-5L in Australia using an adapted EQ-VT: Informing the further development of a revised valuation protocol', 34th EuroQol Plenary Meeting, Barcelona.

Haywood, P., Chin, M., Haas, M. & Viney, R. 2017, 'Modelling the impact of increasing numbers of oncology therapies on the cost-effectiveness of currently reimbursed treatments', 4th European Health Economics Association PhD Student-Supervisor and Early Career Researcher Conference, Lausanne, Switzerland.

Haywood, P., Viney & Haas, M. 2017, 'A model of adaptive reimbursement for sequences of pharmaceuticals in oncology treatment', iHEA Boston World Congress, Boston, USA.

Kenny, P.M. 2017, 'Healthcare funding and patient out-of-pocket costs in Australia', Nurses Symposium: Sickness comes on horseback but departs on foot: addressing the financial impact of haematology treatments on patients and their families, Sydney.

Longden, T. 2017, 'Quelling the impact of hot weather on hospital demand: an analysis of the role of GPs', 10th Health Services and Policy Research Conference, Surfers Paradise.

Manipis, K., Mulhern, B., Haywood, P., Viney, R. & Goodall, S. 2017, 'Estimating the impact of paid and unpaid sick leave on preferences for avoiding the negative impacts of foodborne illnesses, 39th Annual Australian Health Economics Society Conference, Sydney.

Marten, O., Bansback, N., Mulhern, B. & Tsuchiya, A. 2017, 'Modelling implausible EQ-5D-5L states: Prevalence in the general public and its effect on health state valuation – preliminary results', 34th EuroQol Plenary Meeting, Barcelona.

Meshcheriakova, E., Goodall, S. & Viney, R. 2017, 'Consumer preferences for food processing technologies: Evidence from a

discrete choice experiment', iHEA Boston World Congress, Boston, USA.

Mulhern, B., Norman, R., De Abreu Lourenço, R. & Viney, R. 2017, 'Investigating the relative value of health and social care related quality of life using discrete choice', International Society for Pharmacoeconomics and Outcomes Research 22nd Annual International Meeting, Boston, USA.

Mulhern, B., Norman, R., Viney, R., Street, D. & Flattery, M. 2017, 'Assessing the relationship between the EQ-5D-5L descriptive system and a range of outcome measures using psychometric and Rasch analysis', 34th EuroQol Plenary Meeting, Barcelona.

Norman, R., King, M., Viney, R.C., Aaronson, N., Brazier, J., Cella, D., Costa, D., Fayers, P., Kemmler, G., Mercieca-Bebber, R. & Peacock, S. 2017, 'Australian utility weights for the EORTC QLU-CD10, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLU-C30', iHEA Boston World Congress, Boston, USA.

Norman, R., Viney, R., Mulhern, B., Brazier, J., Ratcliffe, J., Lancsar, E., Lorgelly, P., Street, D. & Flattery, M. 2017, 'A large Australian DCE with duration and dead to value EQ-5D-5L health states', 34th EuroQol Plenary Meeting, Barcleona.

Pearce, A., Shaw, J., Lopez, A. & Price, M. 2017, 'Does comorbid anxiety in-crease health resource use or costs among cancer patents? A re-view of the evidence', Clinical Oncology Society of Australia (COSA) Annual Scientific Meeting, Sydney.

Pearce, A.M. 2017, 'Social media as a strategy for career development', Australian Health Economics Doctoral Workshop, Sydney.

Pulok, M., van Gool, K. & Hall, J.P. 2017, 'Revisiting horizontal inequity of health care use: an analysis of regional variation in Australia', iHEA Boston World Congress, Boston, USA.

Pulok, M., Van Gool, K.C. & Hall, J. 2017, 'Revisiting horizontal inequity of health care use: An analysis of regional variation in Australia', 39th Annual Australian Health Economics Society Conference, Sydney.


Saing, S. 2017, 'Modelling the cost-effectiveness of strategies to treat end-stage heart failure using discrete event simulation', 10th Health Services and Policy Research Conference, Surfers Paradise.

Street, D., Mulhern, B., Norman, R. & Viney, R. 2017, 'Using simulations to compare DCE designs that could be used to value EQ-5D', 34th EuroQol Plenary Meeting, Barcelona.

Tomalin, A., Pearce, A.M., Kaambwa, B., Horevoorts, N., Duijts, S., Mols, F., van de Pol, L. & Koczwara, B. 2017, 'Financial toxicity, employment and quality of life of cancer survivors. A secondary analysis of the PROFILES registry', Clinical Oncology Society of Australia (COSA) Annual Scientific Meeting, Sydney.

Van der Linden, N. 2017, 'A Bayesian framework to monitor cost effectiveness over time using real world and randomised study data: the case of bevacizumab in colorectal cancer', 4th European Health Economics Association PhD Student-Supervisor and Early Career Researcher Conference, Lausanne, Switzerland.

Van Gool, K. 2017, 'Effectiveness and equity of cancer screening and treatment: An international perspective [Session Discussant]', iHEA Boston World Congress, Boston, USA.

Viney, R.C. 2017, 'Estimating latent scale discrete choice utilities to develop and EQ-5D-Y value set in the UK (Discussant)', 34th EuroQol Plenary Meeting, Barcelona.

Viney, R.C. 2017, 'Evaluating pharmaceuticals: How far have we come, how much further to go?', Whitlam Policy Forum, Canberra.

Viney, R.C. 2017, 'Line of sight to value for money in the eye drugs', HTA Consumer Workshop, Melbourne.

Viney, R.C. 2017, 'Using Patient Reported Outcome Measures to improve health system performance', Department of Health Roundtable, Canberra.

Viney, R.C., Mulhern, B., Norman, R. & De Abreu Lourenço, R. 2017, 'Investigating the relative value of health and social care related quality of life using discrete choice

experiments', iHEA Boston World Congress, Boston, USA.

White, K., De Abreu Lourenço, R., Kenny, P., Lehane, L. & D'Abrew, N. 2017, 'Dollars and Sense: Exploring the Financial Impact of Cancer for Australian Patients and their Families', MAS-C/ISOO Annual Meeting on Supportive Care in Cancer, Washington, USA.

Woods, M.C. 2017, 'Competition, Regulatory Reform, Productivity Review', Launch of Australia’s ASU4Reform Program, Hanoi, Vietnam.

Woods, M.C. 2017, 'Lessons from Australia’s Growth Path and Policies', Vietnam Development Forum, Hanoi, Vietnam.

Woods, M.C. 2017, 'The Future of Aged Care Funding', The Next Phase of Aged Care Reform, Melbourne.

Woods, M, 2017, 'Workshop on User Choice and Competition in Healthcare' (invited participant), Productivity Commission, Canberra.

Woods, M, 2017, 'The Future of Aged Care', Invited panellist, The Australian Newspaper.

Woods, M, 2017, 'Forum on Consumer Directed Care in residential aged care', guest speaker.


Jody Church presenting her stage 2 assessment for her PhD

Gretchen Togle’s farewell, November 2017

Michael Wright presenting at the Australian Health Economics Society (AHES) Conference, September 2017

Kees van Gool presenting at a CHERE seminar

Gretchen Togle’s farewell November 2017

Mohammad Pulok presenting at the Australian Health Economics Society (AHES) Conference, September 2017


Naomi van der Linden’s farewell April 2018

year in review - uts.edu.au · contracted chere to carry out evaluations of their appraisals....

Documents